This inventor holds 12 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Wyeth, Arqule, Inc., Other. Active years: 2003-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
11 out of 1,309 
5 out of 104 
1 out of 834,513 Years Active: 2003-2010
Title: Joseph Raymond Stock: Innovator in Pharmaceutical Chemistry
Introduction
Joseph Raymond Stock is a notable inventor based in Monroe, NY (US), recognized for his contributions to pharmaceutical chemistry. With a total of 12 patents to his name, he has made significant advancements in the treatment of central nervous system disorders and Alzheimer's disease.
Latest Patents
Among his latest patents, Stock has developed compounds such as N-benzoyl- and N-benzylpyrrolidin-3-ylamines, which serve as histamine-3 antagonists. This invention provides a compound of formula I and outlines its use for treating central nervous system disorders related to or affected by the histamine-3 receptor. Another significant patent involves heterocyclic sulfonamide inhibitors of beta amyloid production. These compounds, defined by specific formulas, are designed to inhibit beta amyloid production and offer potential treatments for Alzheimer's disease and Down's syndrome.
Career Highlights
Throughout his career, Stock has worked with prominent companies in the pharmaceutical industry, including Wyeth and Arqule, Inc. His work has focused on developing innovative solutions to complex medical challenges, particularly in the realm of neuropharmacology.
Collaborations
Stock has collaborated with notable professionals in his field, including Derek Cecil Cole and William Jay Moore. These partnerships have contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Joseph Raymond Stock's innovative work in pharmaceutical chemistry has led to significant advancements in the treatment of various neurological disorders. His contributions continue to impact the field and improve patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile